ONTOLOGY REPORT - ANNOTATIONS
| Term: | Hyperglycemia |
|
| Accession: | RDO:0005838
|
browse the term
|
| Definition: | Abnormally high BLOOD GLUCOSE level. |
| Synonyms: | exact_synonym: | Hyperglycemias; Postprandial Hyperglycemia; Postprandial Hyperglycemias |
| | primary_id: | MESH:D006943 |
|
|
Hyperglycemia
|
| G |
Ada |
adenosine deaminase |
|
|
IEP |
3 |
154,636,530 |
154,660,637 |
RGD:1624290 |
RGD |
| G |
Adipor1 |
adiponectin receptor 1 |
|
|
IEP |
13 |
47,358,625 |
47,379,565 |
RGD:1625765 |
RGD |
| G |
Adrb1 |
adrenoceptor beta 1 |
|
|
IEP |
1 |
263,025,655 |
263,027,055 |
RGD:6893641 |
RGD |
| G |
Adrbk1 |
adrenergic, beta, receptor kinase 1 |
|
|
IED |
1 |
206,873,002 |
206,892,868 |
RGD:1625789 |
RGD |
| G |
Akr1b1 |
aldo-keto reductase family 1, member B1 (aldose reductase) |
|
|
IEP |
4 |
61,645,438 |
61,659,530 |
RGD:1626079 |
RGD |
| G |
Avp |
arginine vasopressin |
|
|
IED |
3 |
118,205,007 |
118,206,985 |
RGD:1601303 |
RGD |
| G |
Bdkrb1 |
bradykinin receptor B1 |
|
|
IED |
6 |
129,760,129 |
129,762,545 |
RGD:704380 |
RGD |
| G |
Cacna1e |
calcium channel, voltage-dependent, R type, alpha 1E subunit |
|
|
ISS |
13 |
69,367,254 |
69,683,943 |
RGD:734670 |
RGD |
| G |
Casp8 |
caspase 8 |
|
|
ISS |
9 |
57,389,353 |
57,437,803 |
RGD:2311428 |
RGD |
| G |
Cntf |
ciliary neurotrophic factor |
|
Induced |
IEP |
1 |
215,842,668 |
215,844,691 |
RGD:1626119 |
RGD |
| G |
Creb1 |
cAMP responsive element binding protein 1 |
|
|
ISS |
9 |
63,170,785 |
63,234,727 |
RGD:734816 |
RGD |
| G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
|
|
IEP |
8 |
61,793,976 |
61,805,308 |
RGD:4785271 |
RGD |
| G |
F2 |
coagulation factor II |
|
|
ISS |
3 |
76,005,318 |
76,018,603 |
RGD:2313851 |
RGD |
| G |
F7 |
coagulation factor VII (serum prothrombin conversion accelerator) |
|
|
ISS |
16 |
81,348,678 |
81,358,991 |
RGD:2312413 |
RGD |
| G |
Gip |
gastric inhibitory polypeptide |
|
|
ISS |
10 |
84,732,705 |
84,740,801 |
RGD:2312590 |
RGD |
| G |
Gipr |
gastric inhibitory polypeptide receptor |
|
|
IEP |
1 |
78,515,051 |
78,526,160 |
RGD:2312603 |
RGD |
| G |
Gipr |
gastric inhibitory polypeptide receptor |
|
|
ISS |
1 |
78,515,051 |
78,526,160 |
RGD:737713 |
RGD |
| G |
Glp1r |
glucagon-like peptide 1 receptor |
|
|
IED |
20 |
9,225,881 |
9,264,184 |
RGD:1624350 |
RGD |
| G |
Hp |
haptoglobin |
|
|
ISS |
19 |
39,443,016 |
39,447,566 |
RGD:1626355 |
RGD |
| G |
Hrh3 |
histamine receptor H3 |
|
|
IED |
3 |
169,154,980 |
169,160,064 |
RGD:1626408 |
RGD |
| G |
Hspd1 |
heat shock protein 1 (chaperonin) |
|
|
IEP |
9 |
53,884,193 |
53,895,043 |
RGD:1624212 |
RGD |
| G |
Hspg2 |
heparan sulfate proteoglycan 2 |
|
|
ISS |
|
|
|
RGD:1624255 |
RGD |
| G |
Htr2a |
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled |
|
|
IED |
15 |
55,463,743 |
55,532,293 |
RGD:1624376 |
RGD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
|
IEP |
8 |
20,040,177 |
20,051,939 |
RGD:4145407 |
RGD |
| G |
Ide |
insulin degrading enzyme |
|
|
IED |
1 |
241,547,869 |
241,646,052 |
RGD:737717 |
RGD |
| G |
Il1a |
interleukin 1 alpha |
|
|
ISS |
3 |
116,913,612 |
116,924,114 |
RGD:2311062 |
RGD |
| G |
Il1b |
interleukin 1 beta |
|
|
IEP |
3 |
116,964,422 |
116,970,867 |
RGD:1626631 |
RGD |
| G |
Il1rn |
interleukin 1 receptor antagonist |
|
|
ISS |
3 |
2,607,800 |
2,613,216 |
RGD:6907426 |
RGD |
| G |
Il6 |
interleukin 6 |
|
|
ISS |
4 |
456,799 |
461,376 |
RGD:2307291 |
RGD |
| G |
Il6 |
interleukin 6 |
|
|
ISS |
4 |
456,799 |
461,376 |
RGD:2307290 |
RGD |
| G |
Insr |
insulin receptor |
|
|
IAGP |
12 |
2,934,967 |
3,087,691 |
RGD:2307333 |
RGD |
| G |
Itgav |
integrin, alpha V |
|
|
ISS |
3 |
66,953,403 |
67,029,774 |
RGD:1627644 |
RGD |
| G |
Ldha |
lactate dehydrogenase A |
|
|
IEP |
1 |
97,403,077 |
97,412,547 |
RGD:1600277 |
RGD |
| G |
Mgrn1 |
mahogunin ring finger 1, E3 ubiquitin protein ligase |
|
|
ISS |
10 |
10,756,804 |
10,805,883 |
RGD:1641947 |
RGD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
|
IEP |
3 |
155,985,473 |
155,993,433 |
RGD:1642027 |
RGD |
| G |
Neurod1 |
neuronal differentiation 1 |
|
|
ISS |
3 |
62,224,633 |
62,227,936 |
RGD:2313477 |
RGD |
| G |
Neurog3 |
neurogenin 3 |
|
|
ISS |
20 |
29,522,778 |
29,524,261 |
RGD:1642077 |
RGD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
|
ISS |
13 |
96,309,670 |
96,341,486 |
RGD:1300264 |
RGD |
| G |
Pck1 |
phosphoenolpyruvate carboxykinase 1 (soluble) |
|
|
ISS |
3 |
164,012,410 |
164,018,359 |
RGD:2311645 |
RGD |
| G |
Pcsk1 |
proprotein convertase subtilisin/kexin type 1 |
|
|
IEP |
2 |
1,923,309 |
1,970,238 |
RGD:2308919 |
RGD |
| G |
Pcsk1 |
proprotein convertase subtilisin/kexin type 1 |
|
|
IED |
2 |
1,923,309 |
1,970,238 |
RGD:2308899 |
RGD |
| G |
Pdx1 |
pancreatic and duodenal homeobox 1 |
|
|
IEP |
|
|
|
RGD:2311207 |
RGD |
| G |
Pdx1 |
pancreatic and duodenal homeobox 1 |
|
|
IEP |
|
|
|
RGD:1600277 |
RGD |
| G |
Pdx1 |
pancreatic and duodenal homeobox 1 |
|
|
ISS |
|
|
|
RGD:2311204 |
RGD |
| G |
Pdx1 |
pancreatic and duodenal homeobox 1 |
|
|
ISS |
|
|
|
RGD:2311206 |
RGD |
| G |
Pdx1 |
pancreatic and duodenal homeobox 1 |
|
|
ISS |
|
|
|
RGD:2308899 |
RGD |
| G |
Pklr |
pyruvate kinase, liver and RBC |
|
|
IEP |
2 |
181,214,853 |
181,223,505 |
RGD:1625587 |
RGD |
| G |
Pla2g4a |
phospholipase A2, group IVA (cytosolic, calcium-dependent) |
|
|
IED |
13 |
64,135,729 |
64,280,815 |
RGD:1642443 |
RGD |
| G |
Ppargc1a |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
|
IED |
14 |
64,278,115 |
64,370,912 |
RGD:7242061 |
RGD |
| G |
Ppargc1a |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
Treatment |
ISS |
14 |
64,278,115 |
64,370,912 |
RGD:7241854 |
RGD |
| G |
Prkcb |
protein kinase C, beta |
|
|
IED |
1 |
181,117,512 |
181,459,856 |
RGD:1625514 |
RGD |
| G |
Prkcz |
protein kinase C, zeta |
|
|
IED |
5 |
172,061,825 |
172,172,793 |
RGD:1642528 |
RGD |
| G |
Prnp |
prion protein |
|
|
IED |
3 |
119,676,137 |
119,691,507 |
RGD:1599950 |
RGD |
| G |
Ptch1 |
patched 1 |
|
|
ISS |
17 |
7,088,234 |
7,142,459 |
RGD:2324911 |
RGD |
| G |
Sdc1 |
syndecan 1 |
|
|
ISS |
6 |
32,253,352 |
32,275,812 |
RGD:1643127 |
RGD |
| G |
Shc1 |
SHC (Src homology 2 domain containing) transforming protein 1 |
|
Susceptibility |
ISS |
2 |
181,616,581 |
181,628,144 |
RGD:1643173 |
RGD |
| G |
Tf |
transferrin |
|
Susceptibility |
ISS |
8 |
108,217,774 |
108,244,487 |
RGD:1601518 |
RGD |
| G |
Tshb |
thyroid stimulating hormone, beta |
|
|
ISS |
2 |
197,908,308 |
197,913,186 |
RGD:1624160 |
RGD |
| Q |
Bw116 |
Body weight QTL 116 |
|
|
QTM |
1 |
229,876,870 |
267,593,558 |
RGD:619678 |
RGD |
| Q |
Cari2 |
Carrageenan-induced inflammation QTL 2 |
|
|
QTM |
2 |
146,659,370 |
210,636,169 |
RGD:61072 |
RGD |
| Q |
Gluco18 |
Glucose level QTL 18 |
|
|
TAS |
1 |
79,749,065 |
124,749,065 |
RGD:1580752 |
RGD |
| Q |
Gluco19 |
Glucose level QTL 19 |
|
|
TAS |
9 |
91,131,330 |
99,799,902 |
RGD:1580752 |
RGD |
| Q |
Gluco20 |
Glucose level QTL 20 |
|
|
TAS |
14 |
78,978,644 |
99,080,020 |
RGD:1580752 |
RGD |
| Q |
Gluco21 |
Glucose level QTL 21 |
|
|
TAS |
2 |
121,545,310 |
163,154,358 |
RGD:1580752 |
RGD |
| Q |
Gluco22 |
Glucose level QTL 22 |
|
|
TAS |
14 |
78,978,644 |
99,080,020 |
RGD:1580752 |
RGD |
| Q |
Gluco23 |
Glucose level QTL 23 |
|
|
TAS |
14 |
76,579,917 |
112,194,335 |
RGD:1580752 |
RGD |
| Q |
Gluco24 |
Glucose level QTL 24 |
|
|
TAS |
15 |
10,138,595 |
55,138,595 |
RGD:1580752 |
RGD |
| Q |
Gluco25 |
Glucose level QTL 25 |
|
|
TAS |
4 |
84,886,545 |
151,158,853 |
RGD:1580752 |
RGD |
| Q |
Gluco26 |
Glucose level QTL 26 |
|
|
TAS |
14 |
78,978,644 |
102,509,397 |
RGD:1580752 |
RGD |
| Q |
Gluco27 |
Glucose level QTL 27 |
|
|
TAS |
14 |
78,978,644 |
99,080,020 |
RGD:1580752 |
RGD |
| Q |
Gluco28 |
Glucose level QTL 28 |
|
|
TAS |
15 |
32,638,412 |
89,569,864 |
RGD:1580752 |
RGD |
| Q |
Gluco29 |
Glucose level QTL 29 |
|
|
TAS |
14 |
78,978,644 |
99,080,020 |
RGD:1580752 |
RGD |
| Q |
Gluco30 |
Glucose level QTL 30 |
|
|
TAS |
15 |
32,638,412 |
89,569,864 |
RGD:1580752 |
RGD |
| Q |
Gluco31 |
Glucose level QTL 31 |
|
|
IED |
15 |
61,458,810 |
102,741,229 |
RGD:619656 |
RGD |
| Q |
Gluco56 |
Glucose level QTL 56 |
|
|
IED |
1 |
205,040,948 |
207,483,209 |
RGD:2316693 |
RGD |
| Q |
Gluco57 |
Glucose level QTL 57 |
|
|
IAGP |
1 |
235,098,616 |
252,340,527 |
RGD:2316856 |
RGD |
| Q |
Gluco58 |
Glucose level QTL 58 |
|
|
IAGP |
4 |
6,690,606 |
185,398,530 |
RGD:2316856 |
RGD |
| Q |
Gluco59 |
Glucose level QTL 59 |
|
|
IAGP |
5 |
17,517,235 |
119,332,868 |
RGD:2316856 |
RGD |
| Q |
Gluco60 |
Glucose level QTL 60 |
|
|
IAGP |
10 |
14,721,135 |
154,166,503 |
RGD:2316856 |
RGD |
| Q |
Iddm21 |
Insulin dependent diabetes mellitus QTL 21 |
|
|
IAGP |
|
|
|
RGD:1547853 |
RGD |
| Q |
Iddm22 |
Insulin dependent diabetes mellitus QTL 22 |
|
|
IAGP |
|
|
|
RGD:1547853 |
RGD |
| Q |
Iddm23 |
Insulin dependent diabetes mellitus QTL 23 |
|
|
IAGP |
|
|
|
RGD:1547853 |
RGD |
| Q |
Niddm14 |
Non-insulin dependent diabetes mellitus QTL 14 |
|
|
QTM |
7 |
90,478,161 |
135,478,161 |
RGD:61072 |
RGD |
| Q |
Niddm21 |
Non-insulin dependent diabetes mellitus QTL 21 |
|
Contributes_to |
IAGP |
8 |
3,039,822 |
61,462,321 |
RGD:2300331 |
RGD |
| Q |
Niddm37 |
Non-insulin dependent diabetes mellitus QTL 37 |
|
|
QTM |
14 |
12,386,493 |
102,509,397 |
RGD:619676 |
RGD |
| Q |
Niddm38 |
Non-insulin dependent diabetes mellitus QTL 38 |
|
|
QTM |
19 |
10,762,811 |
24,725,428 |
RGD:619676 |
RGD |
| Q |
Niddm39 |
Non-insulin dependent diabetes mellitus QTL 39 |
|
|
QTM |
3 |
93,894,678 |
161,985,069 |
RGD:619676 |
RGD |
| Q |
Niddm45 |
Non-insulin dependent diabetes mellitus QTL 45 |
|
|
QTM |
1 |
146,971,983 |
176,854,992 |
RGD:619678 |
RGD |
| Q |
Niddm50 |
Non-insulin dependent diabetes mellitus QTL 50 |
|
|
QTM |
11 |
43,157,054 |
68,234,781 |
RGD:619678 |
RGD |
| Q |
Niddm64 |
Non-insulin dependent diabetes mellitus QTL 64 |
|
|
IED |
1 |
254,291,806 |
254,810,043 |
RGD:1599587 |
RGD |
| Q |
Niddm66 |
Non-insulin dependent diabetes mellitus QTL 66 |
|
|
IED |
1 |
259,866,528 |
260,641,846 |
RGD:1599587 |
RGD |
| S |
BB/N |
|
|
|
TAS |
|
|
|
RGD:1004 |
RGD |
| S |
BBDP/WorN |
|
|
Onset |
IED |
|
|
|
RGD:1578691 |
RGD |
| S |
BBDR.BBDP-(D4Mit6-D4Mit7)/1Rhw |
|
|
Onset |
IED |
4 |
75,732,943 |
75,733,127 |
RGD:2293508 |
RGD |
| S |
BBDR.BBDP-(D4Mit6-D4Mit7)/2Rhw |
|
|
Onset |
IED |
4 |
75,732,943 |
75,733,127 |
RGD:2293508 |
RGD |
| S |
BBDR.BBDP-(D4Mit6-D4Mit7)/3Rhw |
|
|
Onset |
IED |
4 |
75,732,943 |
75,733,127 |
RGD:2293508 |
RGD |
| S |
BBDR.LA-(D5Rat98-D5Rat233)/Rhw |
|
|
Not |
IED |
5 |
100,017,060 |
124,932,061 |
RGD:6893459 |
RGD |
| S |
BBDR/WorN |
|
|
Induced |
IED |
|
|
|
RGD:1578691 |
RGD |
| S |
BN.GK-(D1Wox18-D1Got254)/Ox |
|
|
|
IAGP |
1 |
94,626,541 |
264,367,394 |
RGD:2300263 |
RGD |
| S |
CD |
Cohen diabetic rat |
|
|
QTM |
|
|
|
RGD:1354520 |
RGD |
| S |
F344.GK-(D1Arb42a-D1Rat90)/Swe |
|
|
|
IED |
1 |
267,110,921 |
267,111,153 |
RGD:619677 |
RGD |
| S |
F344.GK-(D1Mgh10-D1Rat119)/Swe |
|
|
|
IED |
1 |
204,280,278 |
242,586,311 |
RGD:619677 |
RGD |
| S |
F344.OLETF-(D11Mgh4-D11Mgh1)/Tj |
|
|
|
TAS |
11 |
61,504,311 |
84,560,241 |
RGD:1302502 |
RGD |
| S |
F344.OLETF-(D12Wox5-D12Rat21)/Tj |
|
|
|
TAS |
12 |
43,801,711 |
43,801,909 |
RGD:1302502 |
RGD |
| S |
F344.OLETF-(D14Rat23-D14Rat12)(D14Rat8-D14Rat26)/Tj |
|
|
|
TAS |
|
|
|
RGD:1302502 |
RGD |
| S |
F344.OLETF-(D14Rat23-D14Rat12)(D8Rat54-D8Mgh17)/Tj |
|
|
|
TAS |
|
|
|
RGD:1302502 |
RGD |
| S |
F344.OLETF-(D14Rat23-D14Rat12)/Tj |
|
|
|
IED |
14 |
1,764,386 |
41,707,592 |
RGD:1643009 |
RGD |
| S |
F344.OLETF-(D14Rat8-D14Rat26)(D14Rat18-D14Rat22)/Tj |
|
|
|
TAS |
|
|
|
RGD:1302502 |
RGD |
| S |
F344.OLETF-(D14Rat8-D14Rat26)/Tj |
|
|
|
TAS |
14 |
32,584,630 |
70,077,314 |
RGD:625760 |
RGD |
| S |
F344.OLETF-(D16Rat19-D16Rat13)/Tj |
|
|
|
TAS |
16 |
35,339,929 |
77,968,799 |
RGD:1302502 |
RGD |
| S |
F344.OLETF-(D1Mit20-D1Mgh26)/Tj |
|
|
|
TAS |
1 |
94,356,875 |
176,616,212 |
RGD:1302502 |
RGD |
| S |
F344.OLETF-(D1Rat166-D1Rat90)/Tj |
|
|
|
TAS |
1 |
255,026,793 |
267,111,153 |
RGD:1302502 |
RGD |
| S |
F344.OLETF-(D5Mgh29-D5Mgh22)/Tj |
|
|
|
TAS |
5 |
157,584,332 |
157,584,492 |
RGD:1302502 |
RGD |
| S |
F344.OLETF-(D5Mgh4-D5Rat21)/Tj |
|
|
|
TAS |
5 |
99,344,678 |
99,344,842 |
RGD:1302502 |
RGD |
| S |
F344.OLETF-(D7Mgh16-D7Mgh20)(D14Rat23-D14Rat12)/Tj |
|
|
|
TAS |
|
|
|
RGD:1302502 |
RGD |
| S |
F344.OLETF-(D7Mgh16-D7Mgh20)(D14Rat8-D14Rat26)/Tj |
|
|
|
TAS |
|
|
|
RGD:1302502 |
RGD |
| S |
F344.OLETF-(D7Mgh16-D7Mgh20)/Tj |
|
|
|
IED |
7 |
103,612,739 |
123,191,874 |
RGD:1643009 |
RGD |
| S |
F344.OLETF-(D7Mgh8-D7Mgh16)(D14Rat23-D14Rat26)/Tj |
|
|
|
TAS |
|
|
|
RGD:1302502 |
RGD |
| S |
F344.OLETF-(D7Mit2-D7Mgh16)(D14Rat23-D14Rat26)/Tj |
|
|
|
TAS |
|
|
|
RGD:1302502 |
RGD |
| S |
F344.OLETF-(D7Rat18-D7Mit2)(D14Rat23-D14Rat12)/Tj |
|
|
|
IED |
|
|
|
RGD:1643009 |
RGD |
| S |
F344.OLETF-(D8Rat54-D8Mgh17)/Tj |
|
|
|
TAS |
8 |
19,796,514 |
73,102,155 |
RGD:1302502 |
RGD |
| S |
F344.OLETF-(D8Rat58-D8Mgh17)/Tj |
|
|
Contributes_to |
IAGP |
8 |
19,796,514 |
48,675,424 |
RGD:2300331 |
RGD |
| S |
F344.OLETF-(D9Mgh8-D9Mit2)/Tj |
|
|
|
TAS |
9 |
33,374,546 |
63,705,951 |
RGD:1302502 |
RGD |
| S |
F344.ZUC-Leprfa(D14Rat23-D14Rat12)/Tj |
|
|
|
TAS |
14 |
1,764,386 |
41,707,592 |
RGD:1302502 |
RGD |
| S |
F344.ZUC-Leprfa(D7Rat16-D7Mgh20)/Tj |
|
|
|
TAS |
7 |
108,647,236 |
108,647,376 |
RGD:1302502 |
RGD |
| S |
F344.ZUC-Leprfa/Tj |
|
|
|
TAS |
|
|
|
RGD:1302502 |
RGD |
| S |
GK/KyoSwe |
Goto Kakizaki |
|
|
IED |
|
|
|
RGD:61061 |
RGD |
| S |
GK/Ox |
|
|
|
IAGP |
|
|
|
RGD:4889455 |
RGD |
| S |
LEW.1AR1-iddm/Ztm |
|
|
|
IAGP |
|
|
|
RGD:1547853 |
RGD |
| S |
NMcwi:HS |
Heterogeneous stock |
|
|
IAGP |
|
|
|
RGD:2316693 |
RGD |
| S |
OLETF |
Otsuka Long-Evans Tokushima fatty |
|
|
TAS |
|
|
|
RGD:1004 |
RGD |
| S |
OLETF/Got |
Otsuka Long Evans Tokushima |
|
|
IED |
|
|
|
RGD:619679 |
RGD |
| S |
SD-Tg(Ins2-IAPP)Soel |
|
|
|
IED |
|
|
|
RGD:2313576 |
RGD |
| S |
SD-Tg(Insr-shRNA)14Bdr |
|
|
Induced |
IED |
|
|
|
RGD:2307333 |
RGD |
| S |
SD-Tg(Insr-shRNA)29Bdr |
|
|
Induced |
IED |
|
|
|
RGD:2307333 |
RGD |
| S |
SDT.ZDF-Leprfa/Jtt |
SDT fatty |
|
|
IED |
|
|
|
RGD:2314022 |
RGD |
| S |
SDT/CrljJcl |
|
|
|
TAS |
|
|
|
RGD:2298688 |
RGD |
| S |
SDT/Jcl |
|
|
|
TAS |
|
|
|
RGD:631173 |
RGD |
| S |
SHR-Tg(PEPCK-SREBF1)2Ipcv |
|
|
|
IED |
|
|
|
RGD:2313691 |
RGD |
| S |
SHR/OlaIpcv-mtBN/Crl |
|
|
|
IED |
|
|
|
RGD:1627567 |
RGD |
Glucose Intolerance
|
| G |
Apoc3 |
apolipoprotein C-III |
|
|
ISS |
|
|
|
RGD:1578441 |
RGD |
| G |
Ccl5 |
chemokine (C-C motif) ligand 5 |
|
|
ISS |
10 |
71,605,791 |
71,610,330 |
RGD:2307103 |
RGD |
| G |
Dusp1 |
dual specificity phosphatase 1 |
|
Resistance |
ISS |
10 |
16,942,913 |
16,945,696 |
RGD:2298673 |
RGD |
| G |
Gipr |
gastric inhibitory polypeptide receptor |
|
|
ISS |
1 |
78,515,051 |
78,526,160 |
RGD:737713 |
RGD |
| G |
Glp1r |
glucagon-like peptide 1 receptor |
|
Susceptibility |
ISS |
20 |
9,225,881 |
9,264,184 |
RGD:1624349 |
RGD |
| G |
Hnf1a |
HNF1 homeobox A |
|
Susceptibility |
ISS |
12 |
42,919,574 |
42,945,670 |
RGD:1601481 |
RGD |
| G |
Inppl1 |
inositol polyphosphate phosphatase-like 1 |
|
|
ISS |
1 |
159,278,131 |
159,292,740 |
RGD:737755 |
RGD |
| G |
Insr |
insulin receptor |
|
|
ISS |
12 |
2,934,967 |
3,087,691 |
RGD:1302523 |
RGD |
| G |
Lipc |
lipase, hepatic |
|
|
ISS |
8 |
75,323,442 |
75,450,353 |
RGD:7240710 |
OMIM |
| G |
Neurod1 |
neuronal differentiation 1 |
|
Susceptibility |
ISS |
3 |
62,224,633 |
62,227,936 |
RGD:1601481 |
RGD |
| G |
Neurog3 |
neurogenin 3 |
|
Susceptibility |
ISS |
20 |
29,522,778 |
29,524,261 |
RGD:1601481 |
RGD |
| G |
Pcsk1 |
proprotein convertase subtilisin/kexin type 1 |
|
|
ISS |
2 |
1,923,309 |
1,970,238 |
RGD:2308929 |
RGD |
| G |
Pon1 |
paraoxonase 1 |
|
|
ISS |
4 |
29,936,314 |
29,964,821 |
RGD:1642628 |
RGD |
| G |
Ppargc1a |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
|
ISS |
14 |
64,278,115 |
64,370,912 |
RGD:7242049 |
RGD |
| G |
Prkaa2 |
protein kinase, AMP-activated, alpha 2 catalytic subunit |
|
|
ISS |
5 |
126,007,672 |
126,074,012 |
RGD:1302556 |
RGD |
| G |
RT1-Ba |
RT1 class II, locus Ba |
|
Susceptibility |
ISS |
20 |
4,697,971 |
4,702,564 |
RGD:2301815 |
RGD |
| G |
Slc27a1 |
solute carrier family 27 (fatty acid transporter), member 1 |
|
|
IEP |
16 |
18,769,909 |
18,786,988 |
RGD:1642794 |
RGD |
| Q |
Gluco6 |
Glucose level QTL 6 |
|
|
IAGP |
7 |
91,775,447 |
119,050,197 |
RGD:619533 |
RGD |
| Q |
Niddm43 |
Non-insulin dependent diabetes mellitus QTL 43 |
|
|
IED |
1 |
204,280,278 |
267,111,153 |
RGD:619677 |
RGD |
| Q |
Niddm44 |
Non-insulin dependent diabetes mellitus QTL 44 |
|
|
IED |
1 |
43,872,827 |
204,280,278 |
RGD:619677 |
RGD |
| Q |
Niddm52 |
Non-insulin dependent diabetes mellitus QTL 52 |
|
|
IED |
7 |
85,089,895 |
98,955,278 |
RGD:619670 |
RGD |
| Q |
Niddm53 |
Non-insulin dependent diabetes mellitus QTL 53 |
|
|
IED |
14 |
4,895,894 |
10,340,377 |
RGD:619670 |
RGD |
| Q |
Niddm54 |
Non-insulin dependent diabetes mellitus QTL 54 |
|
|
IED |
15 |
56,346,569 |
80,370,658 |
RGD:619670 |
RGD |
| Q |
Niddm55 |
Non-insulin dependent diabetes mellitus QTL 55 |
|
|
IED |
15 |
74,779,895 |
80,370,512 |
RGD:619670 |
RGD |
| Q |
Niddm56 |
Non-insulin dependent diabetes mellitus QTL 56 |
|
|
IED |
17 |
38,353,858 |
83,353,858 |
RGD:619670 |
RGD |
| S |
BN.PD-(D8Rat39-D8Rat35),SHR-(D2Mit4-D2Rat28),SHR-(D2Rat103-D2Rat107)/Cub |
|
|
Model |
IED |
|
|
|
RGD:1580751 |
RGD |
| S |
GK/MolTac |
Goto-Kakizaki |
|
|
TAS |
|
|
|
RGD:1559308 |
RGD |
| S |
HTG |
Prague hypertriglyceridemic |
|
|
TAS |
|
|
|
RGD:1303386 |
RGD |
| S |
WOKW |
|
|
|
QTM |
|
|
|
RGD:1357168 |
RGD |
| S |
WOKW/K |
|
|
|
TAS |
|
|
|
RGD:619689 |
RGD |
| S |
ZDF |
Vancouver diabetic fatty Zucker |
|
|
TAS |
|
|
|
RGD:68929 |
RGD |
Term paths to the root
|